Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Claire Pattou"'
Autor:
Martin Kropff, Honorata Giongco Baylon, Jens Hillengass, Tadeusz Robak, Roman Hajek, Peter Liebisch, Stefan Goranov, Cyrille Hulin, Joan Bladé, Tommaso Caravita, Herve Avet-Loiseau, Thomas M. Moehler, Claire Pattou, Lela Lucy, Elisabeth Kueenburg, Axel Glasmacher, Robert Zerbib, Thierry Facon
Publikováno v:
Haematologica, Vol 97, Iss 5 (2012)
Background Thalidomide has potent antimyeloma activity, but no prospective, randomized controlled trial has evaluated thalidomide monotherapy in patients with relapsed/refractory multiple myeloma.Design and Methods We conducted an international, rand
Externí odkaz:
https://doaj.org/article/b15bdc7adca2460fa448a49377a7764a
Autor:
Thomas Moehler, Roman Hájek, Axel Glasmacher, Jens Hillengass, Elisabeth Kueenburg, Thierry Facon, Tadeusz Robak, Peter Liebisch, Cyrille Hulin, Joan Bladé, Claire Pattou, Martin Kropff, Stefan Goranov, Hervé Avet-Loiseau, Lela M. Lucy, Honorata Giongco Baylon, Robert Zerbib, Tommaso Caravita
Background Thalidomide has potent antimyeloma activity, but no prospective, randomized controlled trial has evaluated thalidomide monotherapy in patients with relapsed/refractory multiple myeloma. Design and Methods We conducted an international, ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7f251d396957fda393397208b2115c7
https://europepmc.org/articles/PMC3342984/
https://europepmc.org/articles/PMC3342984/
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 29(2)
The objective of this study was to estimate the global distribution and regional spread of different HIV-1 genetic subtypes and circulating recombinant forms (CRFs) in the year 2000. These estimates were made based on data derived from global HIV/AID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52866686b017cd0120e6e26b115dcccb
https://pubmed.ncbi.nlm.nih.gov/11832690
https://pubmed.ncbi.nlm.nih.gov/11832690
Autor:
Claire Pattou-Markovic, Coumba Toure, Marie Louise Chang, Saladin Osmanov, José Esparza, Stephanie Nixon
Publikováno v:
Vaccine. 20:1897-1898
A safe, effective and accessible preventive vaccine is our best long-term hope for the control of the HIV/AIDS pandemic. The first phase I trial of an HIV vaccine was conducted in the US in 1987. Since then, >30 candidate vaccines have been tested in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbc0f85393a1ca53c9d54ae8f03a761e
https://doi.org/10.1016/s0264-410x(02)00062-2
https://doi.org/10.1016/s0264-410x(02)00062-2